Biochemical fingerprints of prion infection: Accumulations of aberrant full-length and N-terminally truncated PrP species are common features in mouse prion disease

Journal of Virology

Volumn 79, Issue 2, 2005, Pages 934-943

  Pan, Tao ^a   Wong, Poki ^a   Chang, Binggong ^a   Li, Chaoyang ^a   Li, Ruliang ^a   Kang, Shin Chung ^a   Wisniewski, Thomas ^b   Sy, Man Sun ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHYMOTRYPSIN; MUTANT PROTEIN; PAPAIN; PRION PROTEIN; PROTEINASE K;

ADOLESCENT; AMINO TERMINAL SEQUENCE; ARTICLE; BIOCHEMICAL FINGERPRINT; BIOCHEMISTRY; CONTROLLED STUDY; MOUSE; MOUSE SCRAPIE PRION; MOUSE SCRAPIE PRION 139A; MOUSE SCRAPIE PRION 22L; MOUSE SCRAPIE PRION ME7; NONHUMAN; PATHOGENESIS; PRION; PRION DISEASE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN GLYCOSYLATION; PROTEIN POLYMORPHISM; PROTEINASE RESISTANCE; SCRAPIE AGENT; SEDIMENTATION; SUCROSE GRADIENT; SUCROSE GRADIENT VELOCITY SEDIMENTATION;

ANIMALS; BRAIN; GLYCOSYLATION; MICE; PRION DISEASES; PRIONS; PRPC PROTEINS; PRPSC PROTEINS;

EID: 11144247721     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.2.934-943.2005     Document Type: Article

References (53)

1. Aucouturier, P., R. J. Kascsak, B. Frangione, and T. Wisniewski. 1999. Biochemical and conformational variability of human prion strains in sporadic Creutzfeldt-Jakob disease. Neurosci. Lett. 274:33-36.
2. Barren, R. M., and J. C. Manson, 2003. A gene-targeted mouse model of P102L Gerstmann-Straussler-Scheinker syndrome. Clin. Lab. Med. 23:161-173.
3. Bessen, R. A., and R. F. Marsh. 1992. Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent. J. Virol. 66:2096-2101.
4. Bessen, R. A., and R. F. Marsh. 1994. Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J. Virol. 68:7859-7868.
5. Bockman, J. M., and D. T. Kingsbury. 1988. Immunological analysis of host and agent effects on Creutzfeldt-Jakob disease and scrapie prion proteins. J. Virol. 62:3120-3127.
6. Bolton, D. C., M. P. McKinley, and S. B. Prusiner. 1982. Identification of a protein that purifies with the scrapie prion. Science 218:1309-1311.
7. Carp, R. I., S. M. Callahan, E. A. Sersen, and R. C. Moretz. 1984. Preclinical changes in weight of scrapie-infected mice as a function of scrapie agent-mouse strain combination. Intervirology 21:61-69.
8. Collinge, J., K. C. Sidle, J. Meads, J. Ironside, and A. F. Hill. 1996. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 383:685-690.
9. DeArmond, S. J., Y. Qiu, H. Sanchez, P. R. Spilman, A. Ninchak-Casey, D. Alonso, and V. Daggett. 1999. PrPc glycoform heterogeneity as a function of brain region: implications for selective targeting of neurons by prion strains. J. Neuropathol. Exp. Neurol. 58:1000-1009.
10. Dickinson, A. G. 1976. Scrapie in sheep and goats. Front. Biol. 44:209-241.
11. Haraguchi, T., S. Fisher, S. Olofsson, T. Endo, D. Groth, A. Tarentino, D. R. Borchelt, D. Teplow, L. Hood, A. Burlingame, et al. 1989. Asparagine-linked glycosylation of the scrapie and cellular prion proteins. Arch. Biochem. Biophys. 274:1-13.
12. Harris, D. A., R. Chiesa, B. Drisaldi, E. Quaglio, A. Migheli, P. Piccardo, and B. Ghetti. 2003. A murine model of a familial prion disease. Clin. Lab. Med. 23:175-186.
13. Hsiao, K., M. Scott, D. Foster, S. J. DeArmond, D. Groth, H. Serban, and S. B. Prusiner. 1991. Spontaneous neurodegeneration in transgenic mice with prion protein codon 101 proline-leucine substitution. Ann. N. Y. Acad. Sci. 640:166-170.
14. Ironside, J. W., L. McCardle, P. A. Hayward, and J. E. Bell. 1993. Ubiquitin immunocytochemistry in human spongiform encephalopathies. Neuropathol. Appl. Neurobiol. 19:134-140.
15. Kang, S. C., R. Li, C. Wang, T. Pan, T. Liu, R. Rubenstein, G. Barnard, B. S. Wong, and M. S. Sy. 2003. Guanidine hydrochloride extraction and detection of prion proteins in mouse and hamster prion diseases by ELISA. J. Pathol. 199:534-541.
16. a. Kang, S. C., D. R. Brown, M. Whiteman, R. Li, T. Pan, G. Perry, T. Wisniewski, M. S. Sy, and B. S. Wong. 2004. Prion protein is ubiquitinated after developing protease resistance in the brains of scrapie-infected mice. J. Pathol. 203:603-608.
17. Kascsak, R. J., R. Rubenstein, P. A. Merz, R. I. Carp, N. K. Robakis, H. M. Wisniewski, and H. Diringer. 1986. Immunological comparison of scrapie-associated fibrils isolated from animals infected with four different scrapie strains. J. Virol. 59:676-683.
18. Kascsak, R. J., R. Rubenstein, P. A. Merz, M. Tonna-DeMasi, R. Fersko, R. I. Carp, H. M. Wisniewski, and H. Diringer. 1987. Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J. Virol. 61:3688-3693.
19. Kimberlin, R. H., and C. A. Walker. 1979. Pathogenesis of mouse scrapie: dynamics of agent replication in spleen, spinal cord and brain after infection by different routes. J. Comp. Pathol. 89:551-562.
20. Kocisko, D. A., J. H. Come, S. A. Priola, B. Chesebro, G. J. Raymond, P. T. Lansbury, and B. Caughey. 1994. Cell-free formation of protease-resistant prion protein. Nature 370:471-474.
21. Lehmann, S., and D. A. Harris. 1997. Blockade of glycosylation promotes acquisition of scrapie-like properties by the prion protein in cultured cells. J. Biol. Chem. 272:21479-21487. (Erratum, 273:5988, 1998.)
22. Li, R., T. Liu, B.-S. Wong, T. Pan, M. Morillas, W. Swietnicki, K. O'Rourke, P. Gambetti, W. K. Surewicz, and M.-S. Sy. 2000. Identification of an epitope in the C-terminus of normal prion protein whose expression is modulated by binding events in the N-terminus. J. Mol. Biol. 301:567-574.
23. Lu, B. Y., and J. Y. Chang. 2001. Isolation of isoforms of mouse prion protein with PrP(SC)-like structural properties. Biochemistry 40:13390-13396.
24. Ma, J., and S. Lindquist. 2002. Conversion of PrP to a self-perpetuating PrPSc-like conformation in the cytosol. Science. 298:1785-1788.
25. Ma, J., R. Wollmann, and S. Lindquist. 2002. Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol. Science 298:1781-1785.
26. McKinley, M. P., D. C. Bolton, and S. B. Prusiner. 1983. A protease-resistant protein is a structural component of the scrapie prion. Cell 35:57-62.
27. Morillas, M., D. L. Vanik, and W. K. Surewicz. 2001. On the mechanism of alpha-helix to beta-sheet transition in the recombinant prion protein. Biochemistry 40:6982-6987.
28. Oesch, B., D. Westaway, M. Walchli, M. P. McKinley, S. B. Kent, R. Aebersold, R. A. Barry, P. Tempst, D. B. Teplow, and L. E. Hood. 1985. A cellular gene encodes scrapie PrP 27-30 protein. Cell 40:735-746.
29. Outram, G. W. 1976. The pathogenesis of scrapie in mice. Front. Biol. 44:325-357.
30. Pan, K. M., M. Baldwin, J. Nguyen, M. Gasset, A. Serban, D. Groth, I. Mehlhorn, Z. Huang, R. J. Fletterick, F. E. Cohen, and S. B. Prusiner. 1993. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc. Natl. Acad. Sci. USA 90:10962-10966.
31. Pan, T., M. Colucci, B. S. Wong, R. Li, T. Liu, R. B. Petersen, S. Chen, P. Gambetti, and M. S. Sy. 2001. Novel differences between two human prion strains revealed by two-dimensional gel electrophoresis. J. Biol. Chem. 276: 37284-37288.
32. Pan, T., R. Li, S. C. Kang, B. S. Wong, T. Wisniewski, and M. S. Sy. 2004. Epitope scanning reveals gain and loss of strain specific antibody binding epitopes associated with the conversion of normal cellular prion to scrapie prion. J. Neurochem. 90:1205-1217.
33. Pan, T., R. Li, B. S. Wong, T. Liu, P. Gambetti, and M. S. Sy. 2002. Heterogeneity of normal prion protein in two-dimensional immunoblot: presence of various glycosylated and truncated forms. J. Neurochem. 81: 1092-1101.
34. Parchi, P., R. Castellani, S. Capellari, B. Ghetti, K. Young, S. G. Chen, M. Farlow, D. W. Dickson, A. A. Sima, J. Q. Trojanowski, R. B. Petersen, and P. Gambetti. 1996. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann. Neurol. 39:767-778.
35. Parchi, P., A. Giese, S. Capellari, P. Brown, W. Schulz-Schaeffer, O. Windl, I. Zerr, H. Budka, N. Kopp, P. Piccardo, S. Poser, A. Rojiani, N. Streichemberger, J. Julien, C. Vital, B. Ghetti, P. Gambetti, and H. Kretzschmar. 1999. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann. Neurol. 46:224-233.
36. Pattison, I., and G. Millson. 1961. Scrapie produced experimentally in goats with special reference to the clinical syndrome J. Comp. Pathol. 71:101-108.
37. Priola, S. A., and M. Russelakis-Carneiro. 2002. Changes in the glycosylation pattern of prion protein in murine scrapie. Implications for the mechanism of neurodegeneration in prion diseases. J. Biol. Chem. 277:36775-36781.
38. Prusiner, S. B. 1998. Prions. Proc. Natl. Acad. Sci. USA 95:13363-13383.
39. Prusiner, S. B., M. P. McKinley, K. A. Bowman, D. C. Bolton, P. E. Bendheim, D. F. Groth, and G. G. Glenner. 1983. Scrapie prions aggregate to form amyloid-like birefringent rods. Cell 35:349-358.
40. Russelakis-Carneiro, M., G. P. Saborio, L. Anderes, and C. Soto. 2002. Changes in the glycosylation pattern of prion protein in murine scrapie. Implications for the mechanism of neurodegeneration in prion diseases. J. Biol. Chem. 277:36872-36877.
41. Saborio, G. P., B. Permanne, and C. Soto. 2001. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411:810-813.
42. Safar, J., H. Wille, V. Itri, D. Groth, H. Serban, M. Torchia, F. E. Cohen, and S. B. Prusiner. 1998. Eight prion strains have PrP(Sc) molecules with different conformations. Nat. Med. 4:1157-1165.
43. Schulz-Schaeffer, W. J., R. Fatzer, M. Vandevelde, and H. A. Kretzschmar. 2000. Detection of PrP(Sc) in subclinical BSE with the paraffin-embedded tissue (PET) blot. Arch. Virol. Suppl. 16:173-180.
44. Shaked, G. M., G. Fridlander, Z. Meiner, A. Taraboulos, and R. Gabizon. 1999. Protease-resistant and detergent-insoluble prion protein is not necessarily associated with prion infectivity. J. Biol. Chem. 274:17981-17986.
45. Sigurdsson, E. M., M. S. Sy, R. Li, H. Scholtzova, R. J. Kascsak, R. Kascsak, R. Carp, H. C. Meeker, B. Frangione, and T. Wisniewski. 2003. Anti-prion antibodies for prophylaxis following prion exposure in mice. Neurosci. Lett. 336:185-187.
46. Somerville, R. A., and L. A. Ritchie. 1990. Differential glycosylation of the protein (PrP) forming scrapie-associated fibrils. J. Gen. Virol. 71:833-839.
47. Stimson, E., J. Hope, A. Chong, and A. L. Burlingame. 1999. Site-specific characterization of the N-linked glycans of murine prion protein by high-performance liquid chromatography/electrospray mass spectrometry and exoglycosidase digestions. Biochemistry 38:4885-4895.
48. Tzaban, S., G. Friedlander, O. Schonberger, L. Horonchik, Y. Yedidia, G. Shaked, R. Gabizon, and A. Taraboulos. 2002. Protease-sensitive scrapie prion protein in aggregates of heterogeneous sizes. Biochemistry 41:12868-12875.
49. Wadsworth, J. D., A. F. Hill, S. Joiner, G. S. Jackson, A. R. Clarke, and J. Collinge. 1999. Strain-specific prion-protein conformation determined by metal ions. Nat. Cell Biol. 1:55-59.
50. Wille, H., G. F. Zhang, M. A. Baldwin, F. E. Cohen, and S. B. Prusiner. 1996. Separation of scrapie prion infectivity from PrP amyloid polymers. J. Mol. Biol. 259:608-621.
51. Wong, B. S., T. Pan, T. Liu, R. Li, R. B. Petersen, I. M. Jones, P. Gambetti, D. R. Brown, and M. S. Sy. 2000. Prion disease: a loss of antioxidant function? Biochem. Biophys. Res. Commun. 275:249-252.
52. Yedidia, Y., L. Horonchik, S. Tzaban, A. Yanai, and A. Taraboulos. 2001. Proteasomes and ubiquitin are involved in the turnover of the wild-type prion protein EMBO J. 20:5383-5391.
53. Zanusso, G., D. Liu, S. Ferrari, I. Hegyi, X. Yin, A. Aguzzi, S. Hornemann, S. Liemann, R. Glockshuber, J. C. Manson, P. Brown, R. B. Petersen, P. Gambetti, and M. S. Sy. 1998. Prion protein expression in different species: analysis with a panel of new mAbs. Proc. Natl. Acad. Sci. USA. 95:8812-8816.